These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8207931)

  • 1. Method comparison of EMIT 700 and EMIT II with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Anal Toxicol; 1994; 18(2):110-7. PubMed ID: 8207931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening.
    Armbruster DA; Schwarzhoff RH; Hubster EC; Liserio MK
    Clin Chem; 1993 Oct; 39(10):2137-46. PubMed ID: 8403399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Method comparison of EMIT II and online with RIA for drug screening.
    Armbruster DA; Schwarzhoff RH; Pierce BL; Hubster EC
    J Forensic Sci; 1993 Nov; 38(6):1326-41. PubMed ID: 8263477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening.
    Armbruster DA; Hubster EC; Kaufman MS; Ramon MK
    Clin Chem; 1995 Jan; 41(1):92-8. PubMed ID: 7813088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification and evaluation of Abuscreen OnLine assays for drug metabolites in urine performed on a COBAS FARA II in comparison with EMIT d.a.u. Cannabinoid 20.
    Hailer M; Glienke Y; Schwab IM; von Meyer L
    J Anal Toxicol; 1995; 19(2):99-103. PubMed ID: 7769796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the Abuscreen ONLINE assay for amphetamines on the Hitachi 737: comparison with EMIT and GC/MS methods.
    Baker DP; Murphy MS; Shepp PF; Royo VR; Caldarone ME; Escoto B; Salamone SJ
    J Forensic Sci; 1995 Jan; 40(1):108-12. PubMed ID: 7876791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the diagnostic performance of the Boehringer Mannheim CEDIA LSD assay.
    Verstraete AG; Steyaert S
    J Anal Toxicol; 1998; 22(7):601-4. PubMed ID: 9847012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the MTP immunoassay with EMIT in blood screening for drugs].
    Käferstein H; Sticht G
    Arch Kriminol; 1998; 202(5-6):165-72. PubMed ID: 10023491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting benzodiazepines: immunoassays compared with negative chemical ionization gas chromatography/mass spectrometry.
    Fitzgerald RL; Rexin DA; Herold DA
    Clin Chem; 1994 Mar; 40(3):373-80. PubMed ID: 8131270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of DRI enzyme immunoassays for drugs-of-abuse screening on the Cobas Mira.
    Broussard LA; Hanson L
    Clin Lab Sci; 1997; 10(2):83-6. PubMed ID: 10166356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the triage system for emergency drugs-of-abuse testing in urine.
    Wu AH; Wong SS; Johnson KG; Callies J; Shu DX; Dunn WE; Wong SH
    J Anal Toxicol; 1993; 17(4):241-5. PubMed ID: 8371556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precision and comparability of Abuscreen OnLine assays for drugs of abuse screening in urine on Hitachi 917 with other immunochemical tests and with GC/MS.
    Boettcher M; Haenseler E; Hoke C; Nichols J; Raab D; Domke I
    Clin Lab; 2000; 46(1-2):49-52. PubMed ID: 10745981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical performance evaluation of EMIT II monoclonal amphetamine/methamphetamine assay: more specificity than EMIT d.a.u. monoclonal amphetamine/methamphetamine assay.
    Dasgupta A; Saldana S; Kinnaman G; Smith M; Johansen K
    Clin Chem; 1993 Jan; 39(1):104-8. PubMed ID: 8419030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of Syva enzyme multiple immunoassay technique (EMIT) d.a.u. and Roche Abuscreen radioimmunoassay (RIA) (125I) urine cannabinoid immunoassays by gas chromatographic/mass spectrometric (GC/MS) and bonded-phase adsorption/thin-layer chromatographic (BPA-TLC) methods.
    Kogan MJ; Al Razi J; Pierson DJ; Willson NJ
    J Forensic Sci; 1986 Apr; 31(2):494-500. PubMed ID: 3011956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of EMIT and RIA high volume test procedures for THC metabolites in urine utilizing GC/MS confirmation.
    Abercrombie ML; Jewell JS
    J Anal Toxicol; 1986; 10(5):178-80. PubMed ID: 3022068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for drugs of abuse with the Roche ONTRAK assays.
    Armbruster DA; Krolak JM
    J Anal Toxicol; 1992; 16(3):172-5. PubMed ID: 1522711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of immunoassays for cannabinoids in urine.
    Irving J; Leeb B; Foltz RL; Cook CE; Bursey JT; Willette RE
    J Anal Toxicol; 1984; 8(4):192-6. PubMed ID: 6471820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.